Fosun Pharma

completed

Shanghai Fosun Pharmaceuticals Company Limited (Fosun Pharma or the Company) is a leading Chinese pharmaceutical company focused on research, development, production and distribution of pharmaceutical products in China. The Company currently develops, manufactures and sells over 190 formulations and 20 different types of Active Pharmaceutical Ingredients. Its products have leading market positions in the treatment of gynecological and hepatic diseases, diabetes, and malaria. All of the Company’s production facilities are Chinese GMP (Good Manufacturing Practice) compliant. Fosun Pharma also possesses one of the largest wholesale and retail distribution networks for pharmaceutical products in China. The Company holds a 49% stake in Sinopharm Medicine Holding (Sinopharm), one of the largest distributors/retailers in China. China National Pharmaceutical Group (CNPG), a state owned enterprise, owns the remaining 51% in Sinopharm. Together Fosun Pharma and Sinopharm maintain a network of more than 1,500 pharmacies in major cities in China, including Beijing, Shanghai and Shenzhen, and rank as one of top three players in each city.The purpose of the project is to support the operating activities of Fosun Pharma over the next 12-18 months. Fosun Pharma’s total financial requirements in this period are currently estimated at about $100 million.